Literature DB >> 19501922

Role of depression in heart failure--choosing the right antidepressive treatment.

Dimitris Tousoulis1, Alexis S Antonopoulos, Charalambos Antoniades, Chrysa Saldari, Elli Stefanadi, Gerasimos Siasos, Pavlos Stougianos, Aris Plastiras, Porfirios Korompelis, Christodoulos Stefanadis.   

Abstract

Major depression is a common feature of heart failure patients and possibly stems from their common biochemical background. Depression and heart failure co-morbidity has several clinical implications on the prognosis of these patients. Furthermore antidepressive drugs have known cardiovascular side effects, while their safety and efficacy in heart failure has not been fully elucidated yet. The right choice of antidepressive treatment in heart failure constitutes an issue of high importance as it can affect the clinical outcome of these patients. In this article we highlight the role of major depression in heart failure and demonstrate their common biochemical background. Moreover we review the acquired so far knowledge on the use of the various categories of antidepressants in heart failure by reference to the existing clinical studies on antidepressants efficacy and safety in heart failure. Even though certain conclusions cannot be drawn yet, evidence suggests that the use of selective serotonin reuptake inhibitors may have a beneficial effect on clinical outcome of heart failure patients. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19501922     DOI: 10.1016/j.ijcard.2009.05.022

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  A positive 2-item Patient Health Questionnaire depression screen among hospitalized heart failure patients is associated with elevated 12-month mortality.

Authors:  Bruce L Rollman; Bea Herbeck Belnap; Sati Mazumdar; Patricia R Houck; Fanyin He; Rene J Alvarez; Herbert C Schulberg; Charles F Reynolds; Dennis M McNamara
Journal:  J Card Fail       Date:  2011-12-22       Impact factor: 5.712

2.  [Psychopharmacotherapy in patients with cardiovascular diseases].

Authors:  J Cordes; C Lange-Asschenfeldt; C Hiemke; K G Kahl
Journal:  Internist (Berl)       Date:  2012-11       Impact factor: 0.743

Review 3.  The comorbidity conundrum: a focus on the role of noncardiovascular chronic conditions in the heart failure patient.

Authors:  Robert Lee Page; Joann Lindenfeld
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.